PureTech Health plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PENTWATER CAPITAL MANAGEMENT LP | 11/14/2024 | 25,000 | $515,375 | 54.39% | 0.01% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 3,000 | $61,845 | 328.57% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 647 | $13,338 | 84.33% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 100 | $2,062 | -96.46% | 0.00% |
| BIRCH HILL INVESTMENT ADVISORS LLC | 10/10/2024 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
PureTech Health plcinstitutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of PureTech Health plc. The most heavily invested institutionals were:
Pentwater Capital Management LP: 25,000
ADAR1 Capital Management, LLC: 3,000
UBS Group AG: 647
MORGAN STANLEY: 100
Birch Hill Investment Advisors LLC: 0
Tower Research Capital LLC (TRC): 0
0.01% of PureTech Health plc stock is owned by institutional investors.
Institutional investors have bought a total of 28,747 shares in the last 24 months. This purchase volume represents approximately $513,996 in transactions.